A drug delivery systems provider will exhibit its respiratory portfolio at the Drug Delivery to the Lung (DDL) Conference 2018.
Aptar Pharma will also display its range of packaging technologies for respiratory devices at the event.
The company’s exhibition stand will also highlight its range of connected devices. These devices feature fully-connected functionality and software integration, which can improve patient health outcomes through improved adherence.
Chris Baron, director of business development at Aptar Pharma said: “As a leader in inhalation drug delivery systems, we are pleased to be once again showcasing our connected, intuitive and patient-friendly devices at DDL 2018. At Aptar Pharma, we strongly believe that the use of connected devices can help change patient behaviour, which will result in improved medication management and health outcomes. We are dedicated to supporting customers and patients to effectively treat respiratory diseases, and to offer our portfolio of c-Devices such as c-MDIs and c-DPIs.”
Also featured with Aptar Pharma will be Aptar CSP Technologies, now part of AptarGroup Inc. Aptar CSP Technologies offers packaging solutions that aims to protect products to control moisture, extend shelf life and improve performance.
Badre Hammond, associate director of market development at Aptar Pharma, added: “We are pleased to showcase Aptar CSP Technologies’ active packaging solutions amongst the Aptar Pharma range of respiratory product offerings. Their three-Phase Activ-Polymer offers an additional advantage in dry powder inhalers by offering unrivalled moisture protection to extend shelf-life and improve product performance.”
The DDL Conference takes place from December 12-14 in Edinburgh.
